Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Insights and Forecast to 2028

Report ID: 1561636 | Published Date: Oct 2024 | No. of Page: 107 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Surgery
        1.2.3 Targeted Therapy
        1.2.4 Radiation Therapy
        1.2.5 ChemOthersapy
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Ambulatory Surgical Centers
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Perspective (2017-2028)
    2.2 Gastrointestinal Stromal Tumors (GSTs) Treatment Growth Trends by Region
        2.2.1 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Gastrointestinal Stromal Tumors (GSTs) Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Gastrointestinal Stromal Tumors (GSTs) Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Dynamics
        2.3.1 Gastrointestinal Stromal Tumors (GSTs) Treatment Industry Trends
        2.3.2 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Drivers
        2.3.3 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Challenges
        2.3.4 Gastrointestinal Stromal Tumors (GSTs) Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Gastrointestinal Stromal Tumors (GSTs) Treatment Players by Revenue
        3.1.1 Global Top Gastrointestinal Stromal Tumors (GSTs) Treatment Players by Revenue (2017-2022)
        3.1.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue
    3.4 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Concentration Ratio
        3.4.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue in 2021
    3.5 Gastrointestinal Stromal Tumors (GSTs) Treatment Key Players Head office and Area Served
    3.6 Key Players Gastrointestinal Stromal Tumors (GSTs) Treatment Product Solution and Service
    3.7 Date of Enter into Gastrointestinal Stromal Tumors (GSTs) Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Stromal Tumors (GSTs) Treatment Breakdown Data by Type
    4.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Forecasted Market Size by Type (2023-2028)
5 Gastrointestinal Stromal Tumors (GSTs) Treatment Breakdown Data by Application
    5.1 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Gastrointestinal Stromal Tumors (GSTs) Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size (2017-2028)
    6.2 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type
        6.2.1 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2017-2022)
        6.2.2 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2023-2028)
        6.2.3 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Type (2017-2028)
    6.3 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application
        6.3.1 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2017-2022)
        6.3.2 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2023-2028)
        6.3.3 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Application (2017-2028)
    6.4 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country
        6.4.1 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2017-2022)
        6.4.2 North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size (2017-2028)
    7.2 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type
        7.2.1 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2017-2022)
        7.2.2 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2023-2028)
        7.2.3 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Type (2017-2028)
    7.3 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application
        7.3.1 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2017-2022)
        7.3.2 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2023-2028)
        7.3.3 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Application (2017-2028)
    7.4 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country
        7.4.1 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2017-2022)
        7.4.2 Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type
        8.2.1 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Type (2017-2028)
    8.3 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application
        8.3.1 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Application (2017-2028)
    8.4 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region
        8.4.1 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size (2017-2028)
    9.2 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type
        9.2.1 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2017-2022)
        9.2.2 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2023-2028)
        9.2.3 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Type (2017-2028)
    9.3 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application
        9.3.1 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2017-2022)
        9.3.2 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2023-2028)
        9.3.3 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Application (2017-2028)
    9.4 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country
        9.4.1 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2017-2022)
        9.4.2 Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type
        10.2.1 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Type (2017-2028)
    10.3 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application
        10.3.1 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Application (2017-2028)
    10.4 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country
        10.4.1 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.1.4 Pfizer Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
        11.1.5 Pfizer Recent Developments
    11.2 Bayer
        11.2.1 Bayer Company Details
        11.2.2 Bayer Business Overview
        11.2.3 Bayer Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.2.4 Bayer Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
        11.2.5 Bayer Recent Developments
    11.3 Novartis
        11.3.1 Novartis Company Details
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.3.4 Novartis Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
        11.3.5 Novartis Recent Developments
    11.4 Immunicum
        11.4.1 Immunicum Company Details
        11.4.2 Immunicum Business Overview
        11.4.3 Immunicum Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.4.4 Immunicum Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
        11.4.5 Immunicum Recent Developments
    11.5 Roche
        11.5.1 Roche Company Details
        11.5.2 Roche Business Overview
        11.5.3 Roche Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.5.4 Roche Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
        11.5.5 Roche Recent Developments
    11.6 AB Science
        11.6.1 AB Science Company Details
        11.6.2 AB Science Business Overview
        11.6.3 AB Science Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.6.4 AB Science Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
        11.6.5 AB Science Recent Developments
    11.7 Arog Pharmaceuticals
        11.7.1 Arog Pharmaceuticals Company Details
        11.7.2 Arog Pharmaceuticals Business Overview
        11.7.3 Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.7.4 Arog Pharmaceuticals Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
        11.7.5 Arog Pharmaceuticals Recent Developments
    11.8 Boston Biomedical
        11.8.1 Boston Biomedical Company Details
        11.8.2 Boston Biomedical Business Overview
        11.8.3 Boston Biomedical Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.8.4 Boston Biomedical Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
        11.8.5 Boston Biomedical Recent Developments
    11.9 Sun Pharmaceutical
        11.9.1 Sun Pharmaceutical Company Details
        11.9.2 Sun Pharmaceutical Business Overview
        11.9.3 Sun Pharmaceutical Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.9.4 Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
        11.9.5 Sun Pharmaceutical Recent Developments
    11.10 Natco Pharma
        11.10.1 Natco Pharma Company Details
        11.10.2 Natco Pharma Business Overview
        11.10.3 Natco Pharma Gastrointestinal Stromal Tumors (GSTs) Treatment Introduction
        11.10.4 Natco Pharma Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
        11.10.5 Natco Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Surgery
    Table 3. Key Players of Targeted Therapy
    Table 4. Key Players of Radiation Therapy
    Table 5. Key Players of ChemOthersapy
    Table 6. Key Players of Others
    Table 7. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Region (2017-2022)
    Table 11. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Region (2023-2028)
    Table 13. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Trends
    Table 14. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Drivers
    Table 15. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Challenges
    Table 16. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Restraints
    Table 17. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Share by Players (2017-2022)
    Table 19. Global Top Gastrointestinal Stromal Tumors (GSTs) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment as of 2021)
    Table 20. Ranking of Global Top Gastrointestinal Stromal Tumors (GSTs) Treatment Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Gastrointestinal Stromal Tumors (GSTs) Treatment Product Solution and Service
    Table 24. Date of Enter into Gastrointestinal Stromal Tumors (GSTs) Treatment Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Market Share by Type (2017-2022)
    Table 28. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Market Share by Type (2023-2028)
    Table 30. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Share by Application (2017-2022)
    Table 32. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue Share by Application (2023-2028)
    Table 34. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 64. Pfizer Company Details
    Table 65. Pfizer Business Overview
    Table 66. Pfizer Gastrointestinal Stromal Tumors (GSTs) Treatment Product
    Table 67. Pfizer Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022) & (US$ Million)
    Table 68. Pfizer Recent Developments
    Table 69. Bayer Company Details
    Table 70. Bayer Business Overview
    Table 71. Bayer Gastrointestinal Stromal Tumors (GSTs) Treatment Product
    Table 72. Bayer Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022) & (US$ Million)
    Table 73. Bayer Recent Developments
    Table 74. Novartis Company Details
    Table 75. Novartis Business Overview
    Table 76. Novartis Gastrointestinal Stromal Tumors (GSTs) Treatment Product
    Table 77. Novartis Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022) & (US$ Million)
    Table 78. Novartis Recent Developments
    Table 79. Immunicum Company Details
    Table 80. Immunicum Business Overview
    Table 81. Immunicum Gastrointestinal Stromal Tumors (GSTs) Treatment Product
    Table 82. Immunicum Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022) & (US$ Million)
    Table 83. Immunicum Recent Developments
    Table 84. Roche Company Details
    Table 85. Roche Business Overview
    Table 86. Roche Gastrointestinal Stromal Tumors (GSTs) Treatment Product
    Table 87. Roche Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022) & (US$ Million)
    Table 88. Roche Recent Developments
    Table 89. AB Science Company Details
    Table 90. AB Science Business Overview
    Table 91. AB Science Gastrointestinal Stromal Tumors (GSTs) Treatment Product
    Table 92. AB Science Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022) & (US$ Million)
    Table 93. AB Science Recent Developments
    Table 94. Arog Pharmaceuticals Company Details
    Table 95. Arog Pharmaceuticals Business Overview
    Table 96. Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GSTs) Treatment Product
    Table 97. Arog Pharmaceuticals Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022) & (US$ Million)
    Table 98. Arog Pharmaceuticals Recent Developments
    Table 99. Boston Biomedical Company Details
    Table 100. Boston Biomedical Business Overview
    Table 101. Boston Biomedical Gastrointestinal Stromal Tumors (GSTs) Treatment Product
    Table 102. Boston Biomedical Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022) & (US$ Million)
    Table 103. Boston Biomedical Recent Developments
    Table 104. Sun Pharmaceutical Company Details
    Table 105. Sun Pharmaceutical Business Overview
    Table 106. Sun Pharmaceutical Gastrointestinal Stromal Tumors (GSTs) Treatment Product
    Table 107. Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022) & (US$ Million)
    Table 108. Sun Pharmaceutical Recent Developments
    Table 109. Natco Pharma Company Details
    Table 110. Natco Pharma Business Overview
    Table 111. Natco Pharma Gastrointestinal Stromal Tumors (GSTs) Treatment Product
    Table 112. Natco Pharma Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022) & (US$ Million)
    Table 113. Natco Pharma Recent Developments
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Surgery Features
    Figure 3. Targeted Therapy Features
    Figure 4. Radiation Therapy Features
    Figure 5. ChemOthersapy Features
    Figure 6. Others Features
    Figure 7. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Application: 2021 VS 2028
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Ambulatory Surgical Centers Case Studies
    Figure 11. Others Case Studies
    Figure 12. Gastrointestinal Stromal Tumors (GSTs) Treatment Report Years Considered
    Figure 13. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Region: 2021 VS 2028
    Figure 16. Global Gastrointestinal Stromal Tumors (GSTs) Treatment Market Share by Players in 2021
    Figure 17. Global Top Gastrointestinal Stromal Tumors (GSTs) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumors (GSTs) Treatment as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Gastrointestinal Stromal Tumors (GSTs) Treatment Revenue in 2021
    Figure 19. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 20. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2017-2028)
    Figure 21. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2017-2028)
    Figure 22. North America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Share by Country (2017-2028)
    Figure 23. United States Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 26. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2017-2028)
    Figure 27. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2017-2028)
    Figure 28. Europe Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Share by Country (2017-2028)
    Figure 29. Germany Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. France Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. U.K. Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Italy Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Russia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Nordic Countries Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 36. Asia Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2017-2028)
    Figure 37. Asia Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2017-2028)
    Figure 38. Asia Pacific Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Share by Region (2017-2028)
    Figure 39. China Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Japan Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. South Korea Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Southeast Asia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. India Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Australia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 45. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 46. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2017-2028)
    Figure 47. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2017-2028)
    Figure 48. Latin America Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Share by Country (2017-2028)
    Figure 49. Mexico Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Brazil Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 52. Middle East and Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Type (2017-2028)
    Figure 53. Middle East and Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Market Share by Application (2017-2028)
    Figure 54. Middle East and Africa Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size Share by Country (2017-2028)
    Figure 55. Turkey Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. UAE Gastrointestinal Stromal Tumors (GSTs) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Pfizer Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
    Figure 59. Bayer Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
    Figure 60. Novartis Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
    Figure 61. Immunicum Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
    Figure 62. Roche Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
    Figure 63. AB Science Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
    Figure 64. Arog Pharmaceuticals Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
    Figure 65. Boston Biomedical Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
    Figure 66. Sun Pharmaceutical Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
    Figure 67. Natco Pharma Revenue Growth Rate in Gastrointestinal Stromal Tumors (GSTs) Treatment Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Bayer
Novartis
Immunicum
Roche
AB Science
Arog Pharmaceuticals
Boston Biomedical
Sun Pharmaceutical
Natco Pharma
Frequently Asked Questions
Gastrointestinal Stromal Tumors (GSTs) Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gastrointestinal Stromal Tumors (GSTs) Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gastrointestinal Stromal Tumors (GSTs) Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports